Therapeutic Category
- Antineoplastic Agent, Anti-PD-L1 Monoclonal Antibody
- Antineoplastic Agent, Monoclonal Antibody
Medication Safety Issues
Sound-alike/look-alike issues
Avelumab may be confused with atezolizumab, durvalumab, emapalumab, nivolumab.
High alert medication
The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes (chemotherapeutic agent, parenteral and oral) which have a heightened risk of causing significant patient harm when used in error (High-Alert Medications in Acute Care, Community/Ambulatory Care, and Long-Term Care Settings).
